Proposed Section Structure
For this topic, a clinically appropriate structure includes: clinical background and unmet need; trial design and intervention details; efficacy results with quantitative effect estimates; safety and tolerability; clinical interpretation and implications for practice; study limitations and future research needs; and trial registration and citation. This structure fits a digital therapeutic study in a symptomatic chronic condition where both methodological rigor and translational relevance matter.
Highlights
A sham-controlled, double-blind randomized clinical trial found that a therapeutic mobile app for chronic tinnitus produced a substantially greater reduction in Tinnitus Handicap Inventory scores than a sham app at 16 weeks.
The treatment effect was not only statistically significant but clinically notable, with a between-group difference in THI change of -20.4 points at week 16 and persistence of benefit at week 24 after therapeutic functions had been blocked during follow-up.
The intervention combined educational counseling and cognitive behavioral therapy elements, addressing a major access problem in tinnitus care where specialized CBT is often unavailable.
No serious adverse events or device malfunctions with potential health hazards were observed, and tinnitus worsening occurred in 1 patient in the sham-control group.
Background and Unmet Clinical Need
Tinnitus is a common and often frustrating clinical syndrome characterized by the perception of sound in the absence of an external acoustic source. Patients describe ringing, buzzing, hissing, or tonal sounds that may be intermittent or continuous. Although tinnitus can be associated with hearing loss, noise exposure, otologic disease, and a range of neurologic or somatic contributors, one of the most important determinants of clinical burden is not the loudness of the tinnitus itself but the degree of distress, functional impairment, sleep disruption, and mood disturbance it causes.
For patients with chronic bothersome tinnitus, current management is largely supportive rather than curative. Education, hearing rehabilitation when hearing loss is present, and cognitive behavioral therapy have the strongest evidence base among nonpharmacologic interventions. CBT does not eliminate the auditory percept, but it can reduce catastrophic interpretation, hypervigilance, emotional reactivity, and downstream impairment. In many regions, however, access to tinnitus-focused CBT remains limited by workforce constraints, geography, cost, and the lack of standardized delivery pathways. These barriers make digital therapeutics an attractive translational strategy.
Mobile app–based care is particularly relevant in tinnitus because symptom burden is chronic, subjective, and well suited to longitudinal self-monitoring. A digital platform can potentially deliver structured psychoeducation, coping strategies, behavioral exercises, and symptom tracking at scale. The key scientific question is whether such an app provides benefit beyond expectancy, self-monitoring, and simple engagement with a health tool. That is why a sham-controlled trial design is especially important in this field.
Study Design
Wasano and colleagues conducted a double-blind, sham-controlled randomized clinical trial between September 2023 and February 2025 in individuals diagnosed with mild to severe chronic tinnitus. The study tested a prototype mobile application developed as a digital therapeutic for tinnitus. Participants were randomized to either a therapeutic app or a sham-control app lacking the therapeutic functions.
The treatment phase lasted 16 weeks, followed by an 8-week follow-up phase. During follow-up, therapeutic functions were blocked and only the app’s recording function remained available. This design allowed the investigators not only to assess efficacy during active treatment but also to examine whether benefit persisted after withdrawal of the therapeutic content.
The trial enrolled 60 participants, with 30 assigned to the therapeutic app and 30 to sham control. Thirty-three participants were female, representing 55% of the sample. The median age was 58.5 years, with an interquartile range of 52.0 to 64.0 years. Baseline tinnitus-related distress was moderate overall, with a mean THI score of 41.3 and a standard deviation of 16.9.
The primary endpoint was change in Tinnitus Handicap Inventory score from baseline to week 16. THI is a widely used patient-reported measure of tinnitus-related distress and functional impact. Secondary outcomes included repeated THI assessment, Tinnitus Functional Index, numeric rating scales for tinnitus loudness and perceived control, Hospital Anxiety and Depression Scale, Athens Insomnia Scale, and Patient Global Impression of Improvement.
Intervention and Comparator
The active intervention was a therapeutic mobile app that provided educational counseling together with CBT-based elements. While the abstract does not detail each module, the conceptual framework is clinically coherent. Tinnitus-directed education can reduce uncertainty and maladaptive beliefs, while CBT elements can target the emotional and attentional amplification that makes tinnitus disabling. In practice, such elements often include reframing, relaxation or coping exercises, guided attention strategies, symptom logging, and behavioral reinforcement.
The sham-control app served a critical methodological role. It enabled blinding while controlling for smartphone use, interface interaction, and routine symptom recording. In digital health research, improvements can occur from engagement alone, from expectancy effects, or from increased symptom awareness. A sham comparator helps isolate the contribution of the therapeutic components themselves.
Key Results
Primary efficacy outcome
The primary result was compelling. At week 16, participants using the therapeutic app experienced a significantly greater improvement in THI scores than those using the sham-control app. The between-group difference in change was -20.4 points, with a 95% confidence interval of -28.2 to -12.6.
Several features of this result deserve emphasis. First, the confidence interval excludes no effect by a wide margin, indicating robust statistical significance. Second, the magnitude of effect is large enough to be clinically meaningful. In tinnitus studies, changes in THI are often interpreted not only statistically but in terms of whether they reflect a perceptible reduction in daily suffering and disability. A 20-point between-group difference strongly suggests that the observed benefit was not trivial.
Durability of benefit
The therapeutic effect persisted through week 24, even after therapeutic functions had been blocked during the 8-week follow-up period and only recording remained available. The mean between-group difference at week 24 was -18.3 points, with a 95% confidence interval of -26.4 to -10.1.
This sustained separation between groups is clinically important. It suggests that the app may be doing more than producing transient reassurance or short-lived engagement effects. Instead, it may be helping users acquire cognitive and behavioral coping skills that remain useful after active treatment exposure has ended. For chronic tinnitus, where long-term self-management is central, persistence of benefit matters at least as much as short-term symptom reduction.
Secondary outcomes
The abstract states that multiple patient-reported secondary outcomes were assessed, including Tinnitus Functional Index, tinnitus loudness and control numeric rating scales, Hospital Anxiety and Depression Scale, Athens Insomnia Scale, and Patient Global Impression of Improvement. However, detailed numeric results for these secondary endpoints are not provided in the abstract excerpt. As such, interpretation should remain anchored to the clearly reported primary endpoint while recognizing that the broader outcome framework was appropriate for the multidimensional burden of tinnitus.
That multidimensional framework is itself noteworthy. Tinnitus is not merely an auditory symptom. It interacts with sleep, anxiety, depressed mood, concentration, and perceived controllability. A digital therapeutic that improves distress without changing loudness would still be clinically valuable, because functional suffering is the dominant treatment target in many patients.
Safety and tolerability
No serious adverse events or device malfunctions with potential for health hazards were observed. Tinnitus worsened in 1 patient in the sham-control app group. From a digital therapeutic standpoint, this is reassuring. The safety profile appears favorable, particularly compared with interventions that require in-person visits, specialized devices, or medication exposure.
That said, “safe” in digital therapeutics should be interpreted broadly. Beyond traditional adverse events, clinicians should consider the possibility of increased symptom preoccupation, frustration with self-management tasks, low adherence, or delayed referral in patients who need more comprehensive evaluation. Those concerns are not demonstrated here, but they remain relevant to real-world implementation.
Clinical Interpretation
This trial is an important contribution because it addresses a practical problem in tinnitus care: evidence-based treatment exists, but access is poor. CBT is recommended in many tinnitus care pathways, yet few patients can readily obtain it from trained clinicians. A mobile app capable of delivering standardized educational and CBT-informed support could narrow that gap substantially.
The reported effect size is larger than what many clinicians might expect from a low-intensity digital intervention. If replicated, this level of benefit would make the app clinically relevant not as a wellness adjunct but as a meaningful therapeutic option for selected patients with chronic bothersome tinnitus. The sham-controlled design strengthens confidence that the observed gains were not simply due to attention, tracking, or nonspecific app use.
The persistence of benefit after discontinuation of therapeutic functions also aligns with the proposed mechanism of CBT-based care. CBT aims to change appraisal, coping, and attentional responses rather than directly suppress the tinnitus signal. A patient who learns these skills may retain benefit even after active treatment ends. This pattern is biologically and psychologically plausible and fits with contemporary models of tinnitus distress that emphasize central processing, salience attribution, and emotional reinforcement.
From a systems perspective, digital therapeutics may also improve standardization. Usual care for tinnitus varies substantially across settings. An app-based intervention can provide more consistent delivery of key educational and behavioral content, potentially reducing practice variation while expanding reach.
Strengths of the Trial
The study has several notable strengths. First, it used a randomized, double-blind, sham-controlled design, which is more rigorous than many prior digital health studies. Second, it selected a patient-centered primary outcome with direct clinical relevance. Third, it included a follow-up phase that tested durability after active therapeutic functions were withdrawn. Fourth, the intervention addresses an important implementation gap in a prevalent chronic condition with limited scalable treatment options.
The sample, while modest, included patients with mild to severe chronic tinnitus, which supports at least preliminary relevance across a range of symptom burden. The median age of 58.5 years also reflects the demographic reality of many tinnitus clinics, where middle-aged and older adults are commonly represented.
Limitations and Cautions
Despite its strengths, the trial should not be overinterpreted. The sample size was relatively small, with only 60 participants. Small trials can overestimate treatment effects and may be less able to characterize heterogeneity of response. Replication in larger, multicenter populations will be important.
The abstract does not provide granular information on baseline hearing status, tinnitus duration, comorbid psychiatric symptoms, prior treatments, adherence metrics, or subgroup effects. These factors matter clinically. For example, patients with significant hearing loss may derive additional benefit from concurrent hearing aid therapy, while those with prominent anxiety or insomnia may require broader multidisciplinary support.
Generalizability also remains to be established. Digital engagement varies by age, health literacy, comfort with smartphones, and symptom expectations. Effectiveness in real-world practice may differ from efficacy in a controlled trial environment. The extent to which the app can sustain adherence outside a study setting is not yet known.
Another limitation is the lack of detailed secondary endpoint data in the abstract. Without those data, it is difficult to determine whether the benefit was broad-based across mood, sleep, loudness perception, and functional control, or whether improvement was concentrated mainly in tinnitus distress as captured by THI.
Finally, the abstract does not specify the funding source. Transparency regarding sponsorship, software development, commercial interests, and data governance will be important as digital therapeutics move toward broader clinical adoption.
Implications for Practice and Research
For clinicians, this study suggests that app-based CBT-informed tinnitus care may be a reasonable adjunct or access-extending option for adults with distressing chronic tinnitus, especially where specialist CBT is unavailable. It should not replace a standard diagnostic evaluation when red flags are present, such as unilateral tinnitus with asymmetric hearing loss, pulsatile tinnitus, focal neurologic symptoms, or concerning otologic findings. But after appropriate assessment, a validated digital therapeutic could fit naturally into stepped-care models.
For researchers, several next questions are clear. Larger confirmatory trials are needed, ideally with prespecified subgroup analyses and transparent reporting of adherence, engagement patterns, and mediation pathways. Comparative effectiveness studies could test digital therapy against therapist-delivered CBT, hearing-aid–based strategies, or blended care models. Health economic analyses will also be crucial, as scalability is one of the main reasons digital therapeutics are attractive in tinnitus.
In addition, future studies should clarify which patients are most likely to benefit. Predictors could include baseline distress severity, insomnia burden, hearing loss, digital literacy, and cognitive-behavioral profiles. Understanding these factors would help clinicians personalize recommendations rather than treating digital therapeutics as universally interchangeable tools.
Conclusion
This randomized clinical trial provides encouraging evidence that a mobile app delivering educational counseling and CBT elements can substantially reduce tinnitus-related distress in adults with chronic tinnitus. The improvement in THI at 16 weeks was both statistically robust and clinically meaningful, and the benefit persisted through week 24. Safety signals were minimal, with no serious adverse events or device malfunctions reported.
The findings support the broader idea that digital therapeutics can extend evidence-based tinnitus care beyond specialty settings. Still, the study should be viewed as a strong early efficacy signal rather than the final word. Larger studies, real-world implementation data, and health system integration work are needed before this approach can be considered routine standard care. Even so, this trial marks a meaningful step toward scalable, standardized treatment for a condition that remains common, burdensome, and undertreated.
Funding and Trial Registration
Trial registration: jrct.mhlw.go.jp Identifier: 032230359.
Funding: Not reported in the provided abstract excerpt. Readers should consult the full article for funding, conflicts of interest, and developer or commercial involvement disclosures.
References
Wasano K, Kawasaki T, Goto F, Hiraga Y, Nagai S, Tominaga M, Ogawa K. Mobile Application as a Digital Therapeutic for Chronic Tinnitus: A Randomized Clinical Trial. JAMA Otolaryngology–Head & Neck Surgery. Published online May 7, 2026. PMID: 42096236. URL: https://pubmed.ncbi.nlm.nih.gov/42096236/
Fuller T, Cima R, Langguth B, et al. Cognitive behavioural therapy for tinnitus. Cochrane Database of Systematic Reviews. 2020;1(1):CD012614.
Tunkel DE, Bauer CA, Sun GH, et al. Clinical practice guideline: Tinnitus. Otolaryngology–Head and Neck Surgery. 2014;151(2 Suppl):S1-S40.